Bayer Letter on Product Availability During COVID-19

April 9, 2020

The following is a copy of a letter from Bayer. “For more than 30 years, Bayer has been providing FVIII therapies and support programs to people living with hemophilia A. As we all face the current coronavirus (COVID-19) outbreak, the health and safety of our patients continues to be a priority. We realize you may […]

Sign up for E-mails, Dateline Magazine, and other ways to stay connected.